Comments
Loading...

Biohaven Analyst Ratings

BHVNNYSE
Logo brought to you by Benzinga Data
$15.64
0.211.36%
At close: -
$15.64
0.000.00%
After Hours: May 23, 7:57 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$148.50
Lowest Price Target1
$21.00
Consensus Price Target1
$61.16

Biohaven Analyst Ratings and Price Targets | NYSE:BHVN | Benzinga

Biohaven Ltd has a consensus price target of $61.16 based on the ratings of 17 analysts. The high is $148.5 issued by Wedbush on August 8, 2022. The low is $21 issued by RBC Capital on May 19, 2025. The 3 most-recent analyst ratings were released by RBC Capital, RBC Capital, and Baird on May 19, 2025, May 13, 2025, and April 28, 2025, respectively. With an average price target of $44 between RBC Capital, RBC Capital, and Baird, there's an implied 181.33% upside for Biohaven Ltd from these most-recent analyst ratings.

Analyst Trends and Forecast
3
Dec 24
1
Feb
4
Mar
1
Apr
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

RBC Capital
Baird
Morgan Stanley
JP Morgan
HC Wainwright & Co.

1calculated from analyst ratings

Analyst Ratings for Biohaven

Buy NowGet Alert
05/19/2025Buy Now34.27%RBC Capital
Leonid Timashev37%
$54 → $21DowngradeOutperform → Sector PerformGet Alert
05/13/2025Buy Now245.27%RBC Capital
Leonid Timashev37%
$61 → $54MaintainsOutperformGet Alert
04/28/2025Buy Now264.45%Baird
Brian Skorney57%
$60 → $57MaintainsOutperformGet Alert
03/07/2025Buy Now302.81%Morgan Stanley
Terence Flynn64%
$69 → $63MaintainsOverweightGet Alert
03/05/2025Buy Now334.78%JP Morgan
Tessa Romero56%
$72 → $68MaintainsOverweightGet Alert
03/04/2025Buy Now245.27%HC Wainwright & Co.
Douglas Tsao51%
$54 → $54ReiteratesBuy → BuyGet Alert
03/04/2025Buy Now290.03%RBC Capital
Leonid Timashev37%
$61 → $61ReiteratesOutperform → OutperformGet Alert
02/11/2025Buy Now315.6%Deutsche Bank
David Hoang42%
→ $65Initiates → BuyGet Alert
12/17/2024Buy Now—Cantor Fitzgerald
Charles Duncan69%
—ReiteratesOverweight → OverweightGet Alert
12/17/2024Buy Now277.24%HC Wainwright & Co.
Douglas Tsao51%
$59 → $59ReiteratesBuy → BuyGet Alert
12/04/2024Buy Now290.03%RBC Capital
Leonid Timashev37%
$58 → $61ReiteratesOutperform → OutperformGet Alert
11/26/2024Buy Now277.24%HC Wainwright & Co.
Douglas Tsao51%
$59 → $59ReiteratesBuy → BuyGet Alert
11/25/2024Buy Now270.84%RBC Capital
Leonid Timashev37%
$66 → $58MaintainsOutperformGet Alert
11/14/2024Buy Now277.24%HC Wainwright & Co.
Douglas Tsao51%
$59 → $59ReiteratesBuy → BuyGet Alert
11/13/2024Buy Now379.54%TD Cowen
Tyler Van Buren45%
$55 → $75MaintainsBuyGet Alert
11/13/2024Buy Now321.99%RBC Capital
Leonid Timashev37%
$68 → $66MaintainsOutperformGet Alert
10/23/2024Buy Now—Cantor Fitzgerald
Charles Duncan69%
—Reiterates → OverweightGet Alert
10/04/2024Buy Now—Cantor Fitzgerald
Charles Duncan69%
—Reiterates → OverweightGet Alert
10/03/2024Buy Now334.78%JP Morgan
Tessa Romero56%
$55 → $68MaintainsOverweightGet Alert
09/24/2024Buy Now321.99%Bernstein
William Pickering38%
$55 → $66MaintainsOutperformGet Alert
09/24/2024Buy Now296.42%B of A Securities
Jason Gerberry59%
$52 → $62MaintainsBuyGet Alert
09/24/2024Buy Now334.78%RBC Capital
Leonid Timashev37%
$59 → $68MaintainsOutperformGet Alert
09/24/2024Buy Now—Cantor Fitzgerald
Charles Duncan69%
—Reiterates → OverweightGet Alert
09/24/2024Buy Now277.24%HC Wainwright & Co.
Douglas Tsao51%
$59 → $59ReiteratesBuy → BuyGet Alert
09/23/2024Buy Now283.63%Leerink Partners
Marc Goodman73%
$55 → $60MaintainsOutperformGet Alert
09/23/2024Buy Now385.93%Piper Sandler
Christopher Raymond55%
$66 → $76MaintainsOverweightGet Alert
09/23/2024Buy Now283.63%Baird
Brian Skorney57%
$58 → $60MaintainsOutperformGet Alert
09/16/2024Buy Now264.45%Jefferies
Amy Li2%
→ $57Initiates → BuyGet Alert
09/04/2024Buy Now251.66%Bernstein
William Pickering38%
→ $55Initiates → OutperformGet Alert
09/04/2024Buy Now277.24%RBC Capital
Leonid Timashev37%
$59 → $59ReiteratesOutperform → OutperformGet Alert
08/19/2024Buy Now—Cantor Fitzgerald
Charles Duncan69%
—Reiterates → OverweightGet Alert
08/13/2024Buy Now245.27%UBS
Ashwani Verma48%
$55 → $54MaintainsBuyGet Alert
08/12/2024Buy Now—Cantor Fitzgerald
Charles Duncan69%
—Reiterates → OverweightGet Alert
07/24/2024Buy Now270.84%Morgan Stanley
Terence Flynn64%
→ $58Initiates → OverweightGet Alert
06/18/2024Buy Now277.24%RBC Capital
Leonid Timashev37%
$59 → $59ReiteratesOutperform → OutperformGet Alert
05/30/2024Buy Now277.24%HC Wainwright & Co.
Douglas Tsao51%
$59 → $59ReiteratesBuy → BuyGet Alert
05/30/2024Buy Now—Cantor Fitzgerald
Charles Duncan69%
—Reiterates → OverweightGet Alert
05/13/2024Buy Now277.24%HC Wainwright & Co.
Douglas Tsao51%
$63 → $59MaintainsBuyGet Alert
04/23/2024Buy Now283.63%UBS
Ashwani Verma48%
$59 → $60MaintainsBuyGet Alert
04/18/2024Buy Now—Cantor Fitzgerald
Charles Duncan69%
—Reiterates → OverweightGet Alert
04/10/2024Buy Now—Cantor Fitzgerald
Charles Duncan69%
—Reiterates → OverweightGet Alert
04/09/2024Buy Now290.03%RBC Capital
Leonid Timashev37%
$61 → $61ReiteratesOutperform → OutperformGet Alert
03/04/2024Buy Now302.81%HC Wainwright & Co.
Douglas Tsao51%
$50 → $63MaintainsBuyGet Alert
03/01/2024Buy Now290.03%RBC Capital
Leonid Timashev37%
$62 → $61MaintainsOutperformGet Alert
03/01/2024Buy Now251.66%TD Cowen
Tyler Van Buren45%
$35 → $55MaintainsOutperformGet Alert
02/23/2024Buy Now258.06%JP Morgan
Tessa Romero56%
$32 → $56MaintainsOverweightGet Alert
02/16/2024Buy Now296.42%RBC Capital
Leonid Timashev37%
→ $62Initiates → OutperformGet Alert
02/06/2024Buy Now277.24%UBS
Ashwani Verma48%
→ $59Initiates → BuyGet Alert
12/22/2023Buy Now219.69%HC Wainwright & Co.
Douglas Tsao51%
→ $50Initiates → BuyGet Alert
12/08/2023Buy Now270.84%Baird
Brian Skorney57%
→ $58Initiates → OutperformGet Alert
11/20/2023Buy Now104.6%JP Morgan
Tessa Romero56%
$26 → $32MaintainsOverweightGet Alert
11/15/2023Buy Now130.18%Piper Sandler
Christopher Raymond55%
$29 → $36MaintainsOverweightGet Alert
08/16/2023Buy Now53.45%JP Morgan
Tessa Romero56%
$27 → $24MaintainsOverweightGet Alert
07/17/2023Buy Now98.21%Cantor Fitzgerald
Charles Duncan69%
→ $31ReiteratesOverweight → OverweightGet Alert
06/06/2023Buy Now79.03%BTIG
Thomas Shrader39%
$24 → $28Reiterates → BuyGet Alert
04/04/2023Buy Now98.21%Cantor Fitzgerald
Charles Duncan69%
$27 → $31MaintainsOverweightGet Alert
01/24/2023Buy Now53.45%SVB Leerink
Marc Goodman73%
→ $24Initiates → OutperformGet Alert
01/04/2023Buy Now47.06%JP Morgan
Tessa Romero56%
→ $23Initiates → OverweightGet Alert
12/02/2022Buy Now53.45%BTIG
Thomas Shrader39%
→ $24Initiates → BuyGet Alert
10/26/2022Buy Now34.27%Piper Sandler
Christopher Raymond55%
$23 → $21MaintainsOverweightGet Alert
10/12/2022Buy Now47.06%Piper Sandler
Christopher Raymond55%
→ $23Initiates → OverweightGet Alert
08/19/2022Buy Now—Piper Sandler
Christopher Raymond55%
—DowngradeOverweight → NeutralGet Alert
08/08/2022Buy Now849.49%Wedbush
Laura Chico46%
→ $148.5DowngradeOutperform → NeutralGet Alert

FAQ

Q

What is the target price for Biohaven (BHVN) stock?

A

The latest price target for Biohaven (NYSE:BHVN) was reported by RBC Capital on May 19, 2025. The analyst firm set a price target for $21.00 expecting BHVN to rise to within 12 months (a possible 34.27% upside). 37 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Biohaven (BHVN)?

A

The latest analyst rating for Biohaven (NYSE:BHVN) was provided by RBC Capital, and Biohaven downgraded their sector perform rating.

Q

When was the last upgrade for Biohaven (BHVN)?

A

There is no last upgrade for Biohaven

Q

When was the last downgrade for Biohaven (BHVN)?

A

The last downgrade for Biohaven Ltd happened on May 19, 2025 when RBC Capital changed their price target from $54 to $21 for Biohaven Ltd.

Q

When is the next analyst rating going to be posted or updated for Biohaven (BHVN)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biohaven, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biohaven was filed on May 19, 2025 so you should expect the next rating to be made available sometime around May 19, 2026.

Q

Is the Analyst Rating Biohaven (BHVN) correct?

A

While ratings are subjective and will change, the latest Biohaven (BHVN) rating was a downgraded with a price target of $54.00 to $21.00. The current price Biohaven (BHVN) is trading at is $15.64, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch